Kores (India) Limited is a multi-divisional organization and has evolved to become a recognized manufacturer of high grade Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates (PIs) Read More..
Kores (India) Limited is a multi-divisional organization and has evolved to become a recognized manufacturer of high grade Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates (PIs) and the product range include Theophylline, Etofylline, Doxofylline, Aminophylline, 6-Amino-1,3-Dimethyluracil etc. Driven by robust manufacturing processes and stringent quality norms, Kores Pharma produces Theophylline and its advanced derivatives, Mucolytic Expectorant, Diabetic and Cardiovascular drugs, key intermediates for Anticancer and Antiparkinson drugs at its cGMP manufacturing facility at Roha. The company's R&D is equipped with HPLC, FT-IR, GC with Head Space Analyzer and other regular analytical instruments.
The company's focus on innovation has enabled its highly qualified team of researchers to leverage the latest technologies and develop a wide range of products in its Research & Development Centre at Pawane, Navi Mumbai. Kores Pharma team has helped clients across the world to discover greater efficiency and value through their products and high-end services such as custom research and synthesis. Kores Pharma is currently exporting their products to many European, Latin American, South East Asian, Middle East Countries and aims to target highly regulatory market such as US and Japan in the next couple of years.